Alcohol and Opioids

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sharon Walsh; University of Kentucky
• Treatments: Analgesics, Opioid; Ethanol

Criteria

Inclusion Criteria:

• Healthy adults ages 21-55

• Current non-medical use of opioids

• Previous alcohol use

Exclusion Criteria:

• Physical dependence on opioids, alcohol, or benzodiazepines/sedative/hypnotics

• Seeking treatment for drug use

• Significant medical problems